bipolar disorder manic-depressive
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients will be included in the study only if the diagnostic procedure (described next) ascertained a diagnosis of bipolar 1 disorder (DSM-IV-TR: 296.00- .06, 296.40-.46, 296.50-.56, 296.60-.66, 296.7), bipolar 2 disorder (DSM-IV-TR: 296.89), or bipolar disorder NOS (DSM-IV-TR: 296.80).
Exclusion criteria
Exclusion criteria: Patients unable to provide written informed consent due to inability to communicate in Dutch or English, mental retardation (defined as IQ below 70), poor cognition (Mini Mental State Examination (MMSE) below 18) or clinical diagnosis of dementia, or a highly unstable psychiatric condition (e.g. current compulsory admission) were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| exploration of relation between pro-inflammatory cytokines (IL-6) and stage of bipolar disorder | — |
Secondary
| Measure | Time frame |
|---|---|
| none | — |
Countries
Netherlands